Courtney A. Mcdonald

27-31 Wright St
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

Progress in cell therapies for neonatal conditions: Proceedings of the Third Neonatal Cell Therapies Symposium (2025).

Progress in cell therapies for neonatal conditions: Proceedings of the Third Neonatal Cell Therapies Symposium (2025).

Journal: Pediatric research
Published: November 11, 2025

Umbilical cord milking as a technique to harvest cord blood derived cells for regenerative applications.

Umbilical cord milking as a technique to harvest cord blood derived cells for regenerative applications.

Journal: Pediatric research
Published: August 26, 2025

Cord blood-derived cell therapies for preterm brain injury.

Cord blood-derived cell therapies for preterm brain injury.

Journal: Early human development
Published: July 28, 2025

Therapeutic efficacy of genetically engineered neural stem cells in cerebral ischemia: a systematic review and meta-analysis.

Therapeutic efficacy of genetically engineered neural stem cells in cerebral ischemia: a systematic review and meta-analysis.

Journal: Journal of translational medicine
Published: July 07, 2025

Umbilical Cord Blood Endothelial Progenitor Cells Modulate Neurovascular Unit Damage in a Neonatal Rat Model of Hypoxia Ischemia.

Umbilical Cord Blood Endothelial Progenitor Cells Modulate Neurovascular Unit Damage in a Neonatal Rat Model of Hypoxia Ischemia.

Journal: Stem cell reviews and reports
Published: July 06, 2025

Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy: Secondary Analysis of a Nonrandomized Clinical Trial.

Early Neurodevelopment of Extremely Preterm Infants Administered Autologous Cord Blood Cell Therapy: Secondary Analysis of a Nonrandomized Clinical Trial.

Journal: JAMA network open
Published: July 03, 2025

Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol.

Safety and feasibility of allogeneic cord blood-derived cell therapy in preterm infants with severe brain injury (ALLO trial): a phase-1 trial protocol.

Journal: BMJ open
Published: June 18, 2025

Persistent inflammation and white matter damage in the preterm brain: Insights from a novel ovine model of chronic inflammation.

Persistent inflammation and white matter damage in the preterm brain: Insights from a novel ovine model of chronic inflammation.

Journal: Experimental neurology
Published: March 11, 2025

Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024).

Updates on neonatal cell and novel therapeutics: Proceedings of the Second Neonatal Cell Therapies Symposium (2024).

Journal: Pediatric research
Published: December 04, 2024

Effects of Light Exposure duration on Severity and Long-Term Neurodevelopment following Photothrombotic Stroke in a Neonate.

Effects of Light Exposure duration on Severity and Long-Term Neurodevelopment following Photothrombotic Stroke in a Neonate.

Journal: Developmental neuroscience
Published: November 27, 2024

Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study).

Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study).

Journal: EBioMedicine
Published: August 02, 2024

Early Neurodevelopmental Assessments for Predicting Long-Term Outcomes in Infants at High Risk of Cerebral Palsy.

Early Neurodevelopmental Assessments for Predicting Long-Term Outcomes in Infants at High Risk of Cerebral Palsy.

Journal: JAMA network open
Published: May 06, 2024
Showing 1-12 of 69

Last Updated: 09/26/2026